“…Post Hoc tests revealed that the GMC in the two-dose Healive ® group was significantly higher than that in the one-dose Healive ® group (932.4 vs. 112.7 mIU/ml, p < 0.05), and also higher than that in the one-dose attenuated live vaccine groups (932.4 vs. 135. 8,203.3, 212.8 mIU/ml, respectively, p < 0.05). For comparisons among the one-dose vaccines, the GMC in the one-dose Healive ® group was significantly lower than that in the attenuated live vaccine B or C group (112.7 vs. 203.3 or 212.8 mIU/ml, respectively, p < 0.05).…”